US Financial accounts reports.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 85, doi. 10.5912/jcb417
- By:
- Publication type:
- Article
Works matching IS 14628732 AND DT 2001 AND VI 8 AND IP 1
Results: 13
1
2
EU Financial accounts reports.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 81, doi. 10.5912/jcb416
- By:
- Publication type:
- Article
3
Legal and regulatory update.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 73, doi. 10.5912/jcb415
- Publication type:
- Article
4
Cell therapy: European legal and regulatory implications.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 66, doi. 10.5912/jcb414
- By:
- Publication type:
- Article
5
Key indicators of the German equipment and supplies industry.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 59, doi. 10.5912/jcb413
- By:
- Publication type:
- Article
6
Strategies for improving communication between scientists and the public.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 51, doi. 10.5912/jcb412
- By:
- Publication type:
- Article
7
Biomanufacturing capacity: Current and future requirements.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 43, doi. 10.5912/jcb411
- By:
- Publication type:
- Article
8
The European Clinical Trials Directive: What does this mean for the biopharmaceutical industry?
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 37, doi. 10.5912/jcb410
- By:
- Publication type:
- Article
9
The human stem cells debate: A UK perspective.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 31, doi. 10.5912/jcb409
- By:
- Publication type:
- Article
10
Solid organ xenotransplantation: Progress, promise and regulatory issues.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 15, doi. 10.5912/jcb408
- By:
- Publication type:
- Article
11
Becoming a premier partner: Measuring, managing and changing partnering capabilities at Eli Lilly and Company.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 5, doi. 10.5912/jcb407
- By:
- Publication type:
- Article
12
Lessons learned.
- Published in:
- Journal of Commercial Biotechnology, 2001, v. 8, n. 1, p. 3, doi. 10.5912/jcb406
- By:
- Publication type:
- Article
13
Guest Editorial: A civic duty.
- Published in:
- 2001
- By:
- Publication type:
- Editorial